What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News BridgeBio Pharma secures $299m in funding to accelerate genetic disease drug development BridgeBio Pharma, a leading clinical-stage biopharma company specialising in treatments for genetic diseases, has raised $299.2 million in… bypharmanewsdailyFebruary 10, 2019